DIMENSIONAL FUND ADVISORS LP

Position in TYRA — Tyra Biosciences, Inc.

CIK 354204 AUSTIN, TX

Position in TYRA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$6,933,469

+$3,416,535 QoQ

Shares Held

217,078

+136.4% QoQ

Ownership

0.364%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#40

of 169 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 93% Shared 3% None 4%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. TYRA ranks #96 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,933,469	217,078	+136.4%	Shares	Sole	2026-08-11
2026-03-31	$3,516,934	91,826	-4.0%	Shares	Sole	2026-05-07
2025-12-31	$2,514,374	95,640	+141.0%	Shares	Sole	2026-02-12
2025-09-30	$555,107	39,679	-4.8%	Shares	Sole	2025-11-12
2025-06-30	$398,886	41,681	+20.1%	Shares	Sole	2025-08-12
2025-03-31	$322,820	34,712	-8.6%	Shares	Sole	2025-05-13
2024-12-31	$527,934	37,981	+283.4%	Shares	Sole	2025-02-13
2024-09-30	$232,913	9,907	-7.8%	Shares	Defined	2024-11-07
2024-03-31	$176,299	10,750	+1.3%	Shares	Sole	2024-05-10
2023-12-31	$146,933	10,609	0.0%	Shares	Sole	2024-02-07
2023-09-30	$146,085	10,609	+0.1%	Shares	Sole	2023-11-09
2023-06-30	$180,534	10,601	—	Shares	Sole	2023-08-09
No filing history on record for this holder in this stock.